Live Breaking News & Updates on Tscan Therapeutics Company Profile|Page 3

Stay updated with breaking news from Tscan therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in TScan Therapeutics, Inc. (NASDAQ:TCRX) Drops By 24.7%

TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Rating) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 91,700 shares, a drop of 24.7% from the March 31st total of 121,700 shares. Based on an average daily trading volume, of 148,900 shares, […] ....

Tscan Therapeutics Company Profile , Tscan Therapeutics Inc , Millennium Management , Blackrock Inc , Vanguard Group Inc , Alphabet Inc , Get Rating , Therapeutics Company , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx ,

Financial Survey: TScan Therapeutics (TCRX) vs. Its Peers

TScan Therapeutics (NASDAQ:TCRX – Get Rating) is one of 283 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare TScan Therapeutics to related companies based on the strength of its risk, earnings, profitability, analyst recommendations, dividends, institutional ownership and valuation. Risk & Volatility TScan […] ....

United States , Tscan Therapeutics Inc , Tscan Therapeutics Company Profile , Novartis Institutes For Biomedical Research Inc , Get Rating , Therapeutics Company , Novartis Institutes , Biomedical Research , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Stock Comparison , Stock Analysis ,

Financial Contrast: TScan Therapeutics (TCRX) and Its Peers

TScan Therapeutics (NASDAQ:TCRX – Get Rating) is one of 281 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare TScan Therapeutics to related companies based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, dividends and institutional ownership. Analyst Recommendations […] ....

United States , Novartis Institutes For Biomedical Research Inc , Tscan Therapeutics Company Profile , Tscan Therapeutics Inc , Get Rating , Therapeutics Company , Novartis Institutes , Biomedical Research , Therapeutics Daily , Tscan Therapeutics , Nasdaq Tcrx , Stock Comparison , Stock Analysis ,